Biggest News Aggregation in the World
๐Ÿ“ฐ Iagnostics News

Page 79 - Iagnostics News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Iagnostics. Real-time updates on events, politics, business and more.

FUJIREBIO EUROPE: Fujirebio Acquires ADx Neurosciences and Confirms Its Intentions to Bring Better and Earlier Neurodegenerative Disease Diagnostic Solutions to the Global Diagnostics Industry

H.U. Group Holdings Inc., and its wholly-owned subsidiary Fujirebio Holdings, Inc., and ADx NeuroSciences NV today announced the acquisition of ADx NeuroSciences by Fujirebio for 40 million euros. Pending
Koen Dewaele Kostenloser Wertpapierhandel Christiaan De Wilde Fujirebio Europe Hu Group Holdings Inc Public Relations Sustainability Department

Hummingbird Diagnostics GmbH: Hummingbird Diagnostics Publishes Study of miRisk as a Predictor of Immunotherapy Efficacy in Advanced-Stage NSCLC

Proprietary microRNA signature (miRisk) may support immunotherapy treatment decisions as a blood-based complementary diagnostic Results published in Journal of Thoracic Oncology Clinical and Research
Schleswig Holstein Timothy Rajakumar Petros Christopoulos Bruno Steinkraus Karen Sharma Kostenloser Wertpapierhandel

Zion Market Research: At 9.2% CAGR, Scleroderma Diagnostics and Therapeutics Market Size To Hit US$ 4124.6 Million, Globally, By 2028 | Industry Trends, Share, Growth Rate, Value, Analysis & Forecast Report By ZMR

NEW YORK, June 23, 2022 /PRNewswire/ -- As per Zion Market Research study, The global scleroderma diagnostics and therapeutics market was approximately USD 2232.5 million in 2021 and is anticipated
New York United States United Kingdom South Africa South Korea Kostenloser Wertpapierhandel

COVID-19 outcomes improved for SARDs patients through Omicron wave

In a recent study posted to the medRxiv* pre-print server, researchers investigated coronavirus disease 2019 (COVID-19) incidence and severity among systemic autoimmune rheumatic diseases (SARDs) patients in Massachusetts, United States (US), between March 1, 2020, and January 31, 2022.
United States Aimee Molineux Neha Mathur Neha Mathurjun Image Credit Coronavirus Disease Covid 19

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News โ†’

Brain tumor classification can become more accurate with the use of artificial intelligence and physiological imaging

The classification of brain tumors โ€“ and thus the choice of optimal treatment options โ€“ can become more accurate and precise through the use of artificial intelligence in combination with physiological imaging.
Danielle Ellis Andreas Stadlbauer University Hospital Central Institute For Medical Radiology Diagnostics Karl Landsteiner University Health Sciences

Mars Leadership Succession: Grant F. Reid decides to hand over the reins as CEO after driving nearly a decade of unprecedented growth, impact and transformation. Poul Weihrauch to take on role from end of September.

Mars CEO Grant F. Reid has taken the decision to retire from Mars after more than 8 years in the role & 34 years in the business. Under his leadership, Mars has seen unprecedented growth & transformation combined with a focus on sustainability and purpose, and significant expansion into newer areas including veterinary health services. Poul Weihrauch, current Global President at Mars Petcare, will succeed as CEO from the end of September. Reid, who will remain with Mars until the end of ...
Loic Moutault Prnewswire Mars Mars Petcare Frank Mars Cecile Coutens Mars Incorporated

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science